# X4 Pharmaceuticals, Inc: Form DEF 14A, filed Mar 20, 2026

- Company: [X4 Pharmaceuticals, Inc](/companies/xfor.md) (CIK 1501697)
- Form: DEF 14A
- Filed: 2026-03-20
- Accepted by EDGAR: Mar 20, 2026, 08:45 ET
- Period: 2026-03-20
- Accession: 0001501697-26-000031
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1501697/000150169726000031/xfor-20260320.htm

Filed Mar 20, 2026.
Source: SEC EDGAR, the filing index for accession 0001501697-26-000031. Last ingested by Listed: Nov 4, 2026, 16:53 ET. No prices; not investment advice.